Delivery of anti⁃miR34c by polyamidoamine dendrimer attenuates hepatic fibrosis in nude mice
Author:
Affiliation:

(Zhejiang Academy of Medical Sciences Center of Laboratory Animals, Key Laboratory of Experimental Animal and Safety Research of Zhejiang Province, Zhejiang Hangzhou 310013, China)

Clc Number:

Q95-33

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Objective Upregulation of miR34 in the liver has been found in numerous liver diseases, from fatty liver disease to hepatocellular carcinoma. In the present study, we examined the protective actions of anti?miR34c polyamidoamine (PAMAM) dendrimer nanoparticles on hepatic fibrosis in nude mice. Methods Fifteen clean nude mice were randomly divided into the normal control, model control, and anti?miR34c PAMAM dendrimer nanoparticles groups (n =5 per group). Hepatic fibrosis was induced by intraperitoneal injection of 100 μL of 20% carbon tetrachloride twice weekly for 6weeks. Hepatic pathology, serum biochemical indicators, and transforming growth factor?β(TGF?β) / α?smooth muscle cell actin (α?SMA) immunohistochemistry were examined. Results Anti?miR34c delivered by the PAMAM dendrimer decreased inflammatory cell infiltration, collagen deposition, and TGF?β and α?SAM expression in the liver, and improved serum biochemical factors. Conclusions Anti?miR34c PAMAM dendrimer nanoparticles can improve hepatic fibrosis by reducing activation of HSC and incidence of liver injury in nude mice.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:May 04,2018
  • Online: November 09,2018
Article QR Code